{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:26:50Z","timestamp":1793644010120,"version":"4.5.1"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cca.2026.120865","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:08:33Z","timestamp":1769184513000},"page":"120865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Circulating biomarkers in leukemia"],"prefix":"10.1016","volume":"584","author":[{"given":"Aiyun","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Jahedi Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Mirzazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Navid","family":"Khaksari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloofar","family":"Pilehvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Soleimani Samarkhazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s40001-023-01539-z","article-title":"Nanotechnology in leukemia: diagnosis, efficient-targeted drug delivery, and clinical trials","volume":"28","author":"Salama","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40364-025-00738-6","article-title":"Unveiling the potential of CLL-1: a promising target for AML therapy","volume":"13","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Biomark. Res."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0015","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R. I. Med. J."},{"key":"10.1016\/j.cca.2026.120865_bb0020","series-title":"Leukemia: Classification, risk factors, and diagnostic challenges. 2024, ResearchGate. https:\/\/www. researchgate. net\/publication","author":"Karunarathna","year":"2024"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.64336\/001c.92360","article-title":"The readability of online leukemia materials","volume":"8","author":"Choe","year":"2024","journal-title":"Journal of High School Science"},{"key":"10.1016\/j.cca.2026.120865_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251339421","article-title":"Unraveling the clot-miscarriage Nexus: mechanisms, management, and future directions in thrombosis-related recurrent pregnancy loss","volume":"31","author":"Hussein","year":"2025","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"14","key":"10.1016\/j.cca.2026.120865_bb0035","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1389557523666221207155909","article-title":"The role of genetics and synergistic effect of targeting common genetic mutations in acute lymphoblastic leukemia (ALL)","volume":"23","author":"Pilehvari","year":"2023","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cca.2026.120865_bb0040","doi-asserted-by":"crossref","first-page":"132097","DOI":"10.1109\/ACCESS.2021.3114059","article-title":"Automated diagnosis of leukemia: a comprehensive review","volume":"9","author":"Shah","year":"2021","journal-title":"IEEE Access"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0045","first-page":"184","article-title":"Methods of reducing pain during bone marrow biopsy: a narrative review","volume":"4","author":"Zahid","year":"2015","journal-title":"Ann Palliat Med"},{"issue":"7","key":"10.1016\/j.cca.2026.120865_bb0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.crad.2013.01.022","article-title":"Influence of imperfect reference standard bias on the diagnostic performance of MRI in the detection of lymphomatous bone marrow involvement","volume":"68","author":"Adams","year":"2013","journal-title":"Clin. Radiol."},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0055","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.blre.2015.06.003","article-title":"Opportunities and limitations of bone marrow biopsy and bone marrow FDG-PET in lymphoma","volume":"29","author":"Adams","year":"2015","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","article-title":"Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments","volume":"21","author":"Lone","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.annonc.2021.01.074","article-title":"Exosome-based liquid biopsies in cancer: opportunities and challenges","volume":"32","author":"Yu","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymeth.2020.01.008","article-title":"Unraveling the mechanisms that specify molecules for secretion in extracellular vesicles","volume":"177","author":"Leidal","year":"2020","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer: current status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12032-025-02742-0","article-title":"Mesenchymal stem cell-derived exosomes: a novel therapeutic frontier in hematological disorders","volume":"42","author":"Saadh","year":"2025","journal-title":"Med. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4143\/crt.2022.1026","article-title":"Clinical circulating tumor DNA testing for precision oncology","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Research and Treatment: Official Journal of Korean Cancer Association"},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0090","first-page":"28","article-title":"Effect of Harmine alkaloid on the expression of P16 and DAPK in HL60 leukemia cell line. Paramedical sciences and military","volume":"11","author":"Noroozi Aghide","year":"2016","journal-title":"Health"},{"key":"10.1016\/j.cca.2026.120865_bb0095","first-page":"751","article-title":"M2 macrophage-derived exosomes induce angiogenesis and increase skin flap survival through HIF1AN\/HIF-1\u03b1\/VEGFA control","author":"Luo","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0100","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.3390\/cancers12092361","article-title":"Circulating tumor cells: from the laboratory to the cancer clinic","volume":"12","author":"Agashe","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"33","key":"10.1016\/j.cca.2026.120865_bb0110","doi-asserted-by":"crossref","first-page":"55632","DOI":"10.18632\/oncotarget.17184","article-title":"Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer","volume":"8","author":"Jia","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41416-022-02048-2","article-title":"Integrative analysis of multi-omics data for liquid biopsy","volume":"128","author":"Chen","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"23","key":"10.1016\/j.cca.2026.120865_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235696","article-title":"Precision isolation of circulating leukemia cells in chronic myelogenous leukemia patients using a novel microfluidic device and its clinical applications","volume":"15","author":"Ouyang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.120865_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103109","article-title":"ctDNA as a cancer biomarker: a broad overview","volume":"155","author":"Pessoa","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cca.2026.120865_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jdsr.2023.08.004","article-title":"Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer","volume":"59","author":"Rapado-Gonz\u00e1lez","year":"2023","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.cca.2026.120865_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.632910","article-title":"Clinical value of ctDNA in hematological malignancies (lymphomas, multiple myeloma, myelodysplastic syndrome, and leukemia): a Meta-analysis","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.943253","article-title":"Circulating tumor DNA as a Cancer biomarker: an overview of biological features and factors that may impact on ctDNA analysis","volume":"12","author":"S\u00e1nchez-Herrero","year":"2022","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.cca.2026.120865_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16132432","article-title":"Decoding the dynamics of circulating tumor DNA in liquid biopsies","volume":"16","author":"Turabi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.cca.2026.120865_bb0150","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41375-024-02252-4","article-title":"Measurable residual disease (MRD)-testing in haematological and solid cancers","volume":"38","author":"Chen","year":"2024","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.cca.2026.120865_bb0160","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cca.2026.120865_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108271","article-title":"Modeling early treatment response in AML from cell-free tumor DNA","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12943-022-01710-w","article-title":"Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance","volume":"22","author":"Stejskal","year":"2023","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0175","first-page":"26","article-title":"Cell-free DNA for genomic profiling and minimal residual disease monitoring in myeloma- are we there yet?","volume":"10","author":"Thakral","year":"2020","journal-title":"Am J Blood Res"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10238-025-01588-0","article-title":"Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets","volume":"25","author":"Raoufi","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"14","key":"10.1016\/j.cca.2026.120865_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143522","article-title":"Resectable colorectal Cancer: current perceptions on the correlation of recurrence risk, microbiota and detection of genetic mutations in liquid biopsies","volume":"13","author":"Koulouris","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.120865_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-pathmechdis-012419-032604","article-title":"Detection and diagnostic utilization of cellular and cell-free tumor DNA","volume":"16","author":"Dudley","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cca.2026.120865_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.604391","article-title":"Real-time molecular monitoring in acute myeloid leukemia with circulating tumor DNA","volume":"8","author":"Thakral","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40364-025-00786-y","article-title":"Insights into KMT2A rearrangements in acute myeloid leukemia: from molecular characteristics to targeted therapies","volume":"13","author":"Zehtabcheh","year":"2025","journal-title":"Biomark Res"},{"key":"10.1016\/j.cca.2026.120865_bb0205","article-title":"Circulating versus cellular tumor DNA for the detection of BTK resistant CLL clones","volume":"18","author":"Trummer","year":"2022","journal-title":"Leuk Res Rep"},{"issue":"11","key":"10.1016\/j.cca.2026.120865_bb0210","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.26921","article-title":"Association of Circulating Tumor DNA with disease-free survival in breast Cancer: a systematic review and Meta-analysis","volume":"3","author":"Cullinane","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40257-024-00910-y","article-title":"Prognostic biomarkers in evolving melanoma immunotherapy","volume":"26","author":"Reschke","year":"2025","journal-title":"Am. J. Clin. Dermatol."},{"issue":"23","key":"10.1016\/j.cca.2026.120865_bb0220","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.3390\/cancers16233990","article-title":"Patient-specific circulating tumor DNA for monitoring response to Menin inhibitor treatment in preclinical models of infant leukemia","volume":"16","author":"Doculara","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11033-024-10200-9","article-title":"Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53","volume":"52","author":"Rajabi","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0230","first-page":"185","article-title":"Improving the efficacy of vincristine for the treatment of childhood acute lymphoblastic leukemia in a murine model","volume":"8","author":"J\u00fanior","year":"2024","journal-title":"Eurasian Journal of Medicine and Oncology"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0235","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ajh.27586","article-title":"Breaking the bone marrow barrier: peripheral blood as a gateway to measurable residual disease detection in acute myelogenous leukemia","volume":"100","author":"Butler","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cca.2026.120865_bb0240","first-page":"1","article-title":"Galectin-9: a double-edged sword in acute myeloid leukemia","author":"Aval","year":"2025","journal-title":"Ann. Hematol."},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051310","article-title":"The minimal residual disease using liquid biopsies in hematological malignancies","volume":"14","author":"Colmenares","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s42003-024-06181-x","article-title":"Leukemia circulation kinetics revealed through blood exchange method","volume":"7","author":"Miller","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cca.2026.120865_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102977","article-title":"Current concepts and future directions for hemato-oncologic diagnostics","volume":"151","author":"Flach","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0260","first-page":"1044","article-title":"Liquid biopsies in myeloid malignancies","volume":"2","author":"Abdulmawjood","year":"2019","journal-title":"Cancer Drug Resist"},{"issue":"21","key":"10.1016\/j.cca.2026.120865_bb0265","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.3390\/cancers14215378","article-title":"Liquid biopsy in Cancer: focus on lymphoproliferative disorders","volume":"14","author":"Savino","year":"2022","journal-title":"Cancers"},{"issue":"19","key":"10.1016\/j.cca.2026.120865_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910619","article-title":"Microfluidic affinity selection of B-lineage cells from peripheral blood for minimal residual disease monitoring in pediatric B-type acute lymphoblastic leukemia patients","volume":"25","author":"Witek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.120865_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108489","article-title":"Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival","volume":"217","author":"Miyamoto","year":"2020","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0280","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1039\/C5AN01836F","article-title":"Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood","volume":"141","author":"Jackson","year":"2016","journal-title":"Analyst"},{"issue":"10","key":"10.1016\/j.cca.2026.120865_bb0285","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1039\/D4AN00158C","article-title":"Isolation of acute myeloid leukemia blasts from blood using a microfluidic device","volume":"149","author":"Teixeira","year":"2024","journal-title":"Analyst"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41565-024-01774-3","article-title":"Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications","volume":"20","author":"Carney","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.cca.2026.120865_bb0295","first-page":"1","article-title":"Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis","author":"Kubaev","year":"2025","journal-title":"Journal of Liposome Research"},{"key":"10.1016\/j.cca.2026.120865_bb0300","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3389\/fonc.2020.00090","article-title":"Extracellular vesicles and chemotherapy resistance in the AML microenvironment","volume":"10","author":"Nehrbas","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0305","doi-asserted-by":"crossref","first-page":"2003505","DOI":"10.1002\/advs.202003505","article-title":"Shedding light on extracellular vesicle biogenesis and bioengineering","volume":"8","author":"Teng","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.cca.2026.120865_bb0310","first-page":"1","volume":"94","author":"Gon\u00e7alves","year":"2024","journal-title":"Extracellular vesicles. Curr Top Membr"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40364-023-00540-2","article-title":"Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology","volume":"11","author":"Asleh","year":"2023","journal-title":"Biomark. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0320","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40364-024-00661-2","article-title":"The detection, biological function, and liquid biopsy application of extracellular vesicle-associated DNA","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark Res"},{"issue":"15","key":"10.1016\/j.cca.2026.120865_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153827","article-title":"Characteristics and clinical application of extracellular vesicle-derived DNA","volume":"13","author":"Hur","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.120865_bb0330","doi-asserted-by":"crossref","first-page":"1272883","DOI":"10.3389\/fonc.2023.1272883","article-title":"Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients","volume":"13","author":"Longjohn","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119177","article-title":"Extracellular vesicles (EVs): what we know of the mesmerizing roles of these tiny vesicles in hematological malignancies?","volume":"271","author":"Abbaszade Dibavar","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cca.2026.120865_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1677088","article-title":"Exosomal biomarkers in leukemia: translational potential and regulatory challenges for precision medicine applications","volume":"16","author":"Ansarian","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13046-022-02379-1","article-title":"Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer","volume":"41","author":"de Miguel-Perez","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cca.2026.120865_bb0350","doi-asserted-by":"crossref","first-page":"1152470","DOI":"10.3389\/fgene.2023.1152470","article-title":"Enhancing clinical potential of liquid biopsy through a multi-omic approach: a systematic review","volume":"14","author":"Di Sario","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.cca.2026.120865_bb0355","doi-asserted-by":"crossref","first-page":"1442539","DOI":"10.3389\/fgene.2024.1442539","article-title":"Multi-omic analysis of longitudinal acute myeloid leukemia patient samples reveals potential prognostic markers linked to disease progression","volume":"15","author":"Ahmed","year":"2024","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061183","article-title":"Extracellular vesicles in hematological malignancies: from biology to therapy","volume":"18","author":"Caivano","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06030","article-title":"Contribution of extracellular vesicles in normal hematopoiesis and hematological malignancies","volume":"7","author":"Ghafouri-Fard","year":"2021","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010101","article-title":"MiR-26a-5p as a reference to normalize MicroRNA qRT-PCR levels in plasma exosomes of pediatric hematological malignancies","volume":"10","author":"Damanti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cca.2026.120865_bb0375","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2014.00160","article-title":"Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia","volume":"5","author":"Hong","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2026.120865_bb0380","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/821613","article-title":"Role of extracellular vesicles in hematological malignancies","volume":"2015","author":"Raimondo","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.cca.2026.120865_bb0385","doi-asserted-by":"crossref","first-page":"1265969","DOI":"10.3389\/fimmu.2023.1265969","article-title":"Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment","volume":"14","author":"Van Morckhoven","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0390","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00277-019-03608-y","article-title":"Detection of AML-specific mutations in pediatric patient plasma using extracellular vesicle-derived RNA","volume":"98","author":"Kunz","year":"2019","journal-title":"Ann. Hematol."},{"issue":"12","key":"10.1016\/j.cca.2026.120865_bb0395","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1007\/s13277-015-3741-3","article-title":"High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders","volume":"36","author":"Caivano","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2026.120865_bb0400","doi-asserted-by":"crossref","first-page":"1252258","DOI":"10.3389\/fimmu.2024.1252258","article-title":"Detection of minimal residual disease in acute myeloid leukemia: evaluating utility and challenges","volume":"15","author":"\u00c1lvarez","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030599","article-title":"Measurable residual disease detection in acute myeloid leukemia: current challenges and future directions","volume":"12","author":"Moritz","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0410","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2019.235721","article-title":"Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia","volume":"106","author":"Puckrin","year":"2021","journal-title":"Haematologica"},{"issue":"16","key":"10.1016\/j.cca.2026.120865_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15164186","article-title":"Circulating biomarkers associated with the diagnosis and prognosis of B-cell progenitor acute lymphoblastic leukemia","volume":"15","author":"\u00c1lvarez-Z\u00fa\u00f1iga","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2026.120865_bb0420","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1038\/ncomms14756","article-title":"Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cca.2026.120865_bb0425","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3390\/cancers16112049","article-title":"Monitoring response and resistance to treatment in chronic lymphocytic leukemia","volume":"16","author":"Del Giudice","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0430","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.2023022730","article-title":"Acalabrutinib, venetoclax, and obinutuzumab in relapsed\/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial","volume":"144","author":"F\u00fcrstenau","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0435","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3324\/haematol.2019.241208","article-title":"Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas","volume":"106","author":"Bobillo","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0440","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2019.06.011","article-title":"Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction","volume":"178","author":"Kurtz","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0445","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41375-022-01618-w","article-title":"Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research","volume":"36","author":"Lauer","year":"2022","journal-title":"Leukemia"},{"issue":"16_suppl","key":"10.1016\/j.cca.2026.120865_bb0450","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1200\/JCO.2025.43.16_suppl.7040","article-title":"Circulating tumor DNA assessment in patients with early-stage classical Hodgkin lymphoma treated with combination of brentuximab vedotin and nivolumab","volume":"43","author":"Lynch","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0455","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1200\/JCO.22.00826","article-title":"Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas","volume":"41","author":"Mutter","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0460","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.cca.2026.120865_bb0465","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.3390\/cancers12082277","article-title":"Clonal hematopoiesis in liquid biopsy: from biological noise to valuable clinical implications","volume":"12","author":"Chan","year":"2020","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.cca.2026.120865_bb0470","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-18-0143","article-title":"False-positive plasma genotyping due to clonal hematopoiesis","volume":"24","author":"Hu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"26","key":"10.1016\/j.cca.2026.120865_bb0475","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.cca.2026.120865_bb0480","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41591-019-0652-7","article-title":"High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants","volume":"25","author":"Razavi","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050970","article-title":"A review of circulating tumour cell enrichment technologies","volume":"13","author":"Rushton","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"23","key":"10.1016\/j.cca.2026.120865_bb0490","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1200\/JCO.23.02301","article-title":"Next-generation molecular residual disease assays: do we have the tools to evaluate them properly?","volume":"42","author":"Stetson","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0495","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1158\/2643-3230.BCD-21-0029","article-title":"Circulating tumor DNA in lymphoma: principles and future directions","volume":"3","author":"Roschewski","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0500","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00401-016-1536-2","article-title":"Genomic characterization of primary central nervous system lymphoma","volume":"131","author":"Fukumura","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0505","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/bloodadvances.2018027672","article-title":"MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas","volume":"3","author":"Nayyar","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0510","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0515","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3324\/haematol.2019.237719","article-title":"Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study","volume":"106","author":"Camus","year":"2021","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.cca.2026.120865_bb0520","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/bloodadvances.2019001156","article-title":"Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia","volume":"4","author":"Short","year":"2020","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.cca.2026.120865_bb0525","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1182\/bloodadvances.2021006565","article-title":"Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA","volume":"6","author":"Garcia-Gisbert","year":"2022","journal-title":"Blood Adv."},{"issue":"25","key":"10.1016\/j.cca.2026.120865_bb0530","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1182\/blood-2018-10-880690","article-title":"Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS","volume":"133","author":"Nakamura","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0535","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/cas.12994","article-title":"Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes","volume":"107","author":"Suzuki","year":"2016","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.cca.2026.120865_bb0540","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/leu.2016.366","article-title":"Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma","volume":"31","author":"Mithraprabhu","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0545","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12916-017-0840-6","article-title":"Emerging concepts in liquid biopsies","volume":"15","author":"Perakis","year":"2017","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0550","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0555","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12943-019-0989-z","article-title":"The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2026.120865_bb0560","doi-asserted-by":"crossref","first-page":"1164517","DOI":"10.3389\/fonc.2023.1164517","article-title":"Liquid biopsy in hematological malignancies: current and future applications","volume":"13","author":"Talotta","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0565","article-title":"Liquid biopsies and minimal residual disease in myeloid malignancies. Frontiers","volume":"13","author":"Allam","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.cca.2026.120865_bb0570","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctrv.2019.06.002","article-title":"The role of PET\/CT in the modern treatment of Hodgkin lymphoma","volume":"77","author":"Zaucha","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.cca.2026.120865_bb0575","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.medj.2021.09.005","article-title":"Lightning does strike twice: leveraging phased variants to enhance minimal residual disease detection","volume":"2","author":"Cheng","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.cca.2026.120865_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104613","article-title":"Liquid biopsy entering clinical practice: past discoveries, current insights, and future innovations","volume":"207","author":"Song","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.cca.2026.120865_bb0585","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fonc.2015.00107","article-title":"Myeloid derived suppressor cells in chronic myeloid leukemia","volume":"5","author":"Giallongo","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0590","doi-asserted-by":"crossref","first-page":"1304661","DOI":"10.3389\/fgene.2023.1304661","article-title":"Machine learning and multi-omics data in chronic lymphocytic leukemia: the future of precision medicine?","volume":"14","author":"Tsagiopoulou","year":"2023","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0595","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/PPO.0000000000000308","article-title":"Future of liquid biopsies with growing technological and bioinformatics studies: opportunities and challenges in discovering tumor heterogeneity with single-cell level analysis","volume":"24","author":"Ramalingam","year":"2018","journal-title":"Cancer J."},{"issue":"14","key":"10.1016\/j.cca.2026.120865_bb0600","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"G\u00f6kbuget","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.cca.2026.120865_bb0605","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.csbj.2018.10.002","article-title":"Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management","volume":"16","author":"Elazezy","year":"2018","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.cca.2026.120865_bb0610","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1182\/blood-2023-181459","article-title":"Development of circulating tumor DNA (ctDNA) for molecular measurable residual disease (MRD) in acute myeloid leukemia (AML)","volume":"142","author":"Gunaratne","year":"2023","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.cca.2026.120865_bb0615","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/bloodadvances.2023010416","article-title":"Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes","volume":"7","author":"Pasca","year":"2023","journal-title":"Blood Adv."},{"issue":"689","key":"10.1016\/j.cca.2026.120865_bb0620","doi-asserted-by":"crossref","first-page":"eabm8729","DOI":"10.1126\/scitranslmed.abm8729","article-title":"Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing","volume":"15","author":"Fairchild","year":"2023","journal-title":"Sci. Transl. Med."},{"issue":"Supplement 1","key":"10.1016\/j.cca.2026.120865_bb0625","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1182\/blood-2022-169413","article-title":"Cell-free DNA (cfDNA)-based measurable residual disease (MRD) detection as a predictor of relapse post-allogeneic blood or marrow transplant (alloBMT) in patients with myeloid malignancies","volume":"140","author":"Pasca","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cca.2026.120865_bb0630","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jtct.2025.08.010","article-title":"Peripheral blood tumor associated cell-free DNA testing as a predictor for relapse Postallogeneic stem cell transplant for acute myelogenous leukemia","volume":"31","author":"Patel","year":"2025","journal-title":"Transplantation and Cellular Therapy"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0635","doi-asserted-by":"crossref","first-page":"32679","DOI":"10.1038\/s41598-025-20589-3","article-title":"Detection of minimal residual disease in circulating cell-free DNA in acute myeloid leukemia","volume":"15","author":"Sommer","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cca.2026.120865_bb0640","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"136","key":"10.1016\/j.cca.2026.120865_bb0645","doi-asserted-by":"crossref","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","article-title":"Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA","volume":"4","author":"Forshew","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194630","article-title":"Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA","volume":"13","author":"Gale","year":"2018","journal-title":"PloS One"},{"issue":"23","key":"10.1016\/j.cca.2026.120865_bb0655","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1073\/pnas.1105422108","article-title":"Detection and quantification of rare mutations with massively parallel sequencing","volume":"108","author":"Kinde","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0660","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nbt.3520","article-title":"Integrated digital error suppression for improved detection of circulating tumor DNA","volume":"34","author":"Newman","year":"2016","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.cca.2026.120865_bb0665","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/14737159.2019.1627877","article-title":"ClonoSEQ assay for the detection of lymphoid malignancies","volume":"19","author":"Monter","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0670","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12885-020-07077-9","article-title":"Analytical evaluation of the clonoSEQ assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma","volume":"20","author":"Ching","year":"2020","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0675","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.18632\/oncotarget.14448","article-title":"The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma","volume":"8","author":"Sarkozy","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0680","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14737159.2018.1400384","article-title":"Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective","volume":"18","author":"Postel","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.cca.2026.120865_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.bea.2023.100092","article-title":"Medical diagnostic value of digital PCR (dPCR): a systematic review","volume":"6","author":"Nazir","year":"2023","journal-title":"Biomedical Engineering Advances"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0690","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40291-021-00562-2","article-title":"Current and emerging applications of droplet digital PCR in oncology: an updated review","volume":"26","author":"Olmedillas-L\u00f3pez","year":"2022","journal-title":"Mol. Diagn. Ther."},{"issue":"10","key":"10.1016\/j.cca.2026.120865_bb0695","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/14737159.2024.2408744","article-title":"Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma","volume":"24","author":"Fu","year":"2024","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0700","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3390\/diagnostics12061305","article-title":"Digital droplet PCR in hematologic malignancies: a new useful molecular tool","volume":"12","author":"Galimberti","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.cca.2026.120865_bb0705","article-title":"Minimal residual disease detection in lymphoma: methods, procedures and clinical significance","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0710","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/joim.13674","article-title":"Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma","volume":"294","author":"Nagy","year":"2023","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cca.2026.120865_bb0715","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-62703-357-2_14","article-title":"Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma","volume":"999","author":"Yin","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0720","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/etm.2020.8695","article-title":"Effectiveness of digital PCR for MYD88(L265P) detection in vitreous fluid for primary central nervous system lymphoma diagnosis","volume":"20","author":"Chen","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0725","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s12885-024-12191-z","article-title":"Detection of circulating tumor DNA in plasma of patients with primary CNS lymphoma by digital droplet PCR","volume":"24","author":"Zhong","year":"2024","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0730","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/ejh.14191","article-title":"Noninvasive minimal residual disease assessment in relapsed\/refractory large B-cell lymphoma using digital droplet PCR","volume":"112","author":"Heger","year":"2024","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0735","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1038\/s41467-019-11591-1","article-title":"A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing","volume":"10","author":"Petti","year":"2019","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0740","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-Seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0745","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14744\/ejmo.2023.35138","article-title":"Amal Rayan, disturbed expression of memory T-cell subsets could Alter the outcomes in adult acute myeloid leukemia","volume":"7","author":"Zahran","year":"2023","journal-title":"Eurasian Journal of Medicine and Oncology"},{"issue":"12","key":"10.1016\/j.cca.2026.120865_bb0750","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","article-title":"A longitudinal single-cell atlas of treatment response in pediatric AML","volume":"41","author":"Lambo","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0755","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1038\/s41598-020-64929-x","article-title":"Single-cell analysis of childhood leukemia reveals a link between developmental states and ribosomal protein expression as a source of intra-individual heterogeneity","volume":"10","author":"Caron","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.120865_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2025.102041","article-title":"Single-cell sequencing revealed the recurrence causes of ETV6:RUNX1 fusion-positive B-ALL in children","volume":"83","author":"Guan","year":"2025","journal-title":"Mol. Cell. Probes"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0765","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood.2021014669","article-title":"The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia","volume":"141","author":"Nagler","year":"2023","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.cca.2026.120865_bb0770","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood.2021013926","article-title":"Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib","volume":"139","author":"Purroy","year":"2022","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0775","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1158\/2643-3230.BCD-24-0342","article-title":"Single-cell transcriptional atlas of human hematopoiesis reveals genetic and hierarchy-based determinants of aberrant AML differentiation","volume":"6","author":"Zeng","year":"2025","journal-title":"Blood Cancer Discovery"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0780","doi-asserted-by":"crossref","DOI":"10.1002\/dro2.92","article-title":"Recent advances in droplet-based microfluidics in liquid biopsy for cancer diagnosis","volume":"3","author":"Shi","year":"2024","journal-title":"Droplet"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0785","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10238-025-01686-z","article-title":"Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation","volume":"25","author":"Bishoyi","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"9","key":"10.1016\/j.cca.2026.120865_bb0790","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1039\/D5AN00105F","article-title":"Advancements and innovations in liquid biopsy through microfluidic technology for cancer diagnosis","volume":"150","author":"Abusara","year":"2025","journal-title":"Analyst"},{"issue":"6","key":"10.1016\/j.cca.2026.120865_bb0795","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41551-019-0356-9","article-title":"Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip","volume":"3","author":"Zhang","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cca.2026.120865_bb0800","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.snb.2018.03.118","article-title":"Multiwalled carbon nanotube modified microfluidic-based biosensor chip for nucleic acid detection","volume":"266","author":"Ghrera","year":"2018","journal-title":"Sens. Actuators B"},{"key":"10.1016\/j.cca.2026.120865_bb0805","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood-2023-189824","article-title":"Phased variants allow robust profiling of circulating tumor DNA in untreated follicular lymphomas","volume":"142","author":"Nagy","year":"2023","journal-title":"Blood"},{"issue":"7329","key":"10.1016\/j.cca.2026.120865_bb0810","first-page":"337","article-title":"Fragmentation patterns and personalized sequencing of plasma DNA in cancer patients","volume":"469","author":"Mouliere","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.120865_bb0815","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","article-title":"Circulating cell free DNA: preanalytical considerations","volume":"424","author":"El Messaoudi","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0820","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0825","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41571-020-00457-x","article-title":"Liquid biopsy enters the clinic\u2014implementation issues and future challenges","volume":"18","author":"Ignatiadis","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0830","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11033-025-10527-x","article-title":"C-type lectin-like molecule-1 as a diagnostic, prognostic, and therapeutic marker in leukemia","volume":"52","author":"Soleimani Samarkhazan","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.cca.2026.120865_bb0835","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/gcc.22517","article-title":"A field guide for cancer diagnostics using cell-free DNA: from principles to practice and clinical applications","volume":"57","author":"Volckmar","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cca.2026.120865_bb0840","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41698-019-0102-5","article-title":"Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochip","volume":"3","author":"Khoo","year":"2019","journal-title":"NPJ Precis Oncol"},{"issue":"13","key":"10.1016\/j.cca.2026.120865_bb0845","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/cancers14133272","article-title":"Liquid biopsy in prostate Cancer management\u2014current challenges and future perspectives","volume":"14","author":"Crocetto","year":"2022","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.cca.2026.120865_bb0850","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2017.76.8671","article-title":"Circulating tumor DNA analysis in patients with Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review","volume":"36","author":"Merker","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2026.120865_bb0855","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/cancers14051139","article-title":"The practicality of the use of liquid biopsy in early diagnosis and treatment monitoring of oral cancer in resource-limited settings","volume":"14","author":"Adeola","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cca.2026.120865_bb0860","article-title":"Recommendations for the equitable and widespread implementation of liquid biopsy for cancer care","volume":"8","author":"Febbo","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.cca.2026.120865_bb0865","doi-asserted-by":"crossref","DOI":"10.1177\/11772719231204508","article-title":"Multiomic approaches for Cancer biomarker discovery in liquid biopsies: advances and challenges","volume":"18","author":"Diaz","year":"2023","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.cca.2026.120865_bb0870","first-page":"30","article-title":"The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia","author":"M\u00e1rton","year":"2024","journal-title":"Pathology oncology research\u202f: POR"},{"issue":"20","key":"10.1016\/j.cca.2026.120865_bb0875","first-page":"2127","article-title":"Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy. Blood, the journal of the American society of","volume":"140","author":"Thijssen","year":"2022","journal-title":"Hematology"},{"issue":"4","key":"10.1016\/j.cca.2026.120865_bb0880","doi-asserted-by":"crossref","first-page":"237","DOI":"10.62347\/EBRY4326","article-title":"And Zheng, Q, cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring","volume":"14","author":"Dong","year":"2025","journal-title":"American Journal of Clinical and Experimental Immunology"},{"key":"10.1016\/j.cca.2026.120865_bb0885","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymeth.2021.08.001","article-title":"NetAUC: a network-based multi-biomarker identification method by AUC optimization","volume":"198","author":"Li","year":"2022","journal-title":"Methods (San Diego, Calif.)"},{"issue":"1","key":"10.1016\/j.cca.2026.120865_bb0890","first-page":"1","article-title":"Role of precision medicine and personalized medicine in the treatment of diseases","volume":"3","author":"Farrokhi","year":"2023","journal-title":"Kindle"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:05Z","timestamp":1793640665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":178,"alternative-id":["S0009898126000471"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120865","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating biomarkers in leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120865"}}